KLRK1 and infection: IL-12/18 treatment also increased the proportion of CD8+ T cells that were NKG2D+ and enhanced NKG2D expression on the CD8+ T cells, suggesting that IL-12/18 signaling in vivo in the context of infection can enhance bystander T cell activation and function (Fig. 6e, f).